Collagen Crosslinking for Keratoconus: Cellular Signaling Mechanisms
Collagen crosslinking (CXL) is a widely used treatment to halt the progression of keratoconus (KC). Unfortunately, a significant number of patients with progressive KC will not qualify for CXL, including those with corneas thinner than 400 µm. The present study aimed to investigate the molecular eff...
Main Authors: | Dimitrios Karamichos, Sarah E. Nicholas, Asher Khan, Kamran M. Riaz |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-04-01
|
Series: | Biomolecules |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-273X/13/4/696 |
Similar Items
-
MyoRing Implantation with and without Corneal Collagen Crosslinking for the Management of Keratoconus
by: Mehrdad Mohammadpour, et al.
Published: (2020-10-01) -
Corneal collagen crosslinking for keratoconus. A review
by: M. M. Bikbov, et al.
Published: (2014-10-01) -
Transepithelial accelerated versus conventional corneal collagen crosslinking in patients with keratoconus: a comparative study
by: Madeira C, et al.
Published: (2019-03-01) -
Comparative 2-year outcomes of conventional and accelerated corneal collagen crosslinking in progressive keratoconus
by: Ömür Ö. Uçakhan, et al.
Published: (2020-08-01) -
Efectividad del crosslinking del colágeno corneal en el tratamiento del queratocono Effectiveness of the corneal collagen crosslinking in the treatment of keratoconus
by: Madelyn Jareño Ochoa, et al.
Published: (2012-12-01)